Morgan Stanley’s Baird Medical Investment Holdings BDMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$39.2K Buy
+20,000
New +$33.4K ﹤0.01% 6509
2025
Q3
Sell
-8,734
Closed -$32K 8425
2025
Q2
$32K Sell
8,734
-4,433
-34% -$23.2K ﹤0.01% 6503
2025
Q1
$68.6K Buy
+13,167
New +$78.9K ﹤0.01% 6165

Other funds holding BDMD

Morgan Stanley's BDMD Position: Q1 2026 in Review

Morgan Stanley opened a new position in Baird Medical Investment Holdings (BDMD) in Q1 2026: 20,000 shares worth $39.2K. The stake represents ﹤0.01% of the portfolio and ranks #6509 among its holdings. This is a return to the name: Morgan Stanley previously reported a position in BDMD as recently as Q2 2025.

Morgan Stanley first reported a position in BDMD in Q1 2025 and has held it in 3 quarters since. The position peaked at $68.6K in Q1 2025. 8 funds tracked by Wall St. Rank hold BDMD as of Q1 2026.

  • Morgan Stanley held 20,000 shares of Baird Medical Investment Holdings worth $39.2K as of Q1 2026.
  • Baird Medical Investment Holdings was a new Morgan Stanley position in Q1 2026.
  • Baird Medical Investment Holdings made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #6509 holding.
  • Morgan Stanley first reported a position in Baird Medical Investment Holdings in Q1 2025 and has held it in 3 quarters since.
  • Morgan Stanley's Baird Medical Investment Holdings position peaked at $68.6K in Q1 2025.
  • 8 funds tracked by Wall St. Rank held Baird Medical Investment Holdings as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.